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Abstract
Gestational age (GA) and birth weight have been implicated in the determination of long-term health. It has been hypothesized
that changes in DNAmethylationmaymediate these long-term effects.We obtainedDNAmethylation profiles from cord blood
and peripheral blood at ages 7 and 17 in the same children from theAvon Longitudinal Studyof Parents andChildren. Repeated-
measures data were used to investigate changes in birth-related methylation during childhood and adolescence. Ten
developmental phenotypes (e.g. height) were analysed to identify possible mediation of health effects by DNAmethylation. In
cord blood, methylation at 224 CpG sites was found to be associated with GA and 23 CpG sites with birth weight. Methylation
changed in themajority of these sites over time, but neither birth characteristicwas strongly associatedwithmethylation at age
7 or 17 (using a conservative correction formultiple testing of P < 1.03 × 10–7), suggesting resolution of differentialmethylation by
early childhood. Associations were observed between birth weight-associated CpG sites and phenotypic characteristics in
childhood. One strong association involved birthweight,methylation of a CpG site proximal to theNFIX locus and bonemineral
density at age 17. Analysis of serial methylation from birth to adolescence provided evidence for a lack of persistence of
methylation differences beyond early childhood. Sites associated with birth weight were linked to developmental genes and
have methylation levels which are associated with developmental phenotypes. Replication and interrogation of causal
relationships are needed to substantiate whether methylation differences at birth influence the association between birth
weight and development.
Introduction
Gestational age (GA) and birthweight have been implicated in the
determination of long-term health (1–4) and may mediate their
persistent biological effects via epigenetic mechanisms (5–8).
This is predicated on the notion that epigenetic changes induced
in utero or early postnatal life persists across the life course; a
hypothesis that pervades the Developmental Origins of Health
and Disease (DOHaD) literature (9,10) and has been underpinned
by observations such as the widely cited Dutch Hunger Winter
Studies (11–13).
Previous studies have reported an association between DNA
methylation (a form of epigenetic modification) measured in
cord blood and GA at delivery (5–7) and birth weight (8). These
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studies have included either appraisal of preterm birth or
GA across the normal range, although it is clear that both
have potentially very different determinants and underlying
mechanisms.
Previous investigation of the relationship between DNA
methylation and GA includes a study by Schroeder et al. (5) that
detected 41 cytosine bases (CpG sites) showing differential
methylation in relation to GA in 39 genes using a cohort of 259
neonates frommothers with a history of neuropsychiatric disor-
ders. They replicated their findings for 26 of these sites (in 25
genes) using a sample of 194 newborns from healthy mothers.
Many of the identified CpG sites were within genes implicated
in labour, delivery and development of later adverse health out-
comes. Similarly, Lee et al. (6) identified several differentially
methylated regions of the epigenome which were associated
with GA. These regions were adjacent to three genes involved
in early development (NFIX, RAPGEF2 and MSRB3). Further sup-
port for an association of DNA methylation and GA comes from
a study by Parets et al. (7) who performed an epigenome-wide
association study (EWAS) on 50 newborns, of whom 22 were pre-
term deliveries. They identified 9637 CpG sites with methylation
levels associatedwith GA.With respect to birthweight, in a study
of 1046 infants, Engel et al. (8) reported 19 CpG sites to be asso-
ciatedwith cord blood DNAmethylation levels; some of the iden-
tified CpG sites were within genes that had previously been
associated with roles in adipogenesis [ARID5B (14)] and DNA
repair [XRCC3 (15,16)]. Tan et al. (17) foundno epigenome-wide as-
sociations between birth weight andmethylation from a study of
150 pairs of adult monozygotic twins (median age 57, range
30–74) who were discordant for birth weight. However, they
identified three CpG sites in a sub-sample of twins who were
extremely discordant for birth weight.
Studies have also been conducted in the context of preterm
birth, which by definition is a category of low GA and thus closely
correlates with low birth weight (18,19). A recent study (19) iden-
tified 1555 CpG sites with differential methylation between term
and preterm newborns in a matched case–control study. A key
finding was that many of these differences had been resolved by
adulthood, suggesting that methylation difference at delivery
(when not at term) merely reflects methylation changes during a
normal developmental trajectory. Whether these differences in
early life affect later phenotypic development has not yet been
explored.
Physiological or molecular changes induced in early life have
the potential to have profound developmental consequences and
implications for health across the life course (20–22). Although
previous studies have attempted to consider the persistence of
DNA methylation from birth to adulthood, they have been se-
verely limited by analysing DNA methylation at a single time
point—either sampled at birth and compared cross-sectionally
with birth weight (8) and GA (5–7) or sampled in childhood or
adulthood and compared retrospectively with birth weight
and GA [or other exposures such as prenatal famine (11)].
‘Change’ in DNA methylation, i.e. difference detected over
time, has been the focus of several studies to date (23–32).
Many of these report on cross-sectional samples (26,28), adult
populations (25) or both (27,29,30,32). Appraisal of change over
time in individuals requires measurement of DNA methylation
at more than a single time point. A small number of studies
have included two time points of serially measured DNA
methylation (23,24,31,33,34). However, while two serial mea-
surements are useful, they are limited to the study of linear
change, i.e. the difference in methylation from one clinic to
the next.
This study sought to analyse DNAmethylation in serial sam-
ples from the same individuals at three time points from birth to
age 17. Focus was placed on the identification of methylation
variable sites associated with birth weight and GA, these being
two exposures clearly associated with long-term health conse-
quences. Ten developmental phenotypes (e.g. bone mineral
density and weight) were used to identify potential mediation
of the birth-development association by DNA methylation.
Results
There were 914, 973 and 974 samples with blood DNA methyla-
tion profiles obtained using the Illumina InfiniumHumanMethy-
lation450 BeadChip (Illumina, Inc.) (35). This arraymeasures DNA
methylation simultaneously at over 485 000 CpG sites across the
human genome. After a quality control (QC) step (see Materials
and Methods), we obtained DNA methylation in cord blood
(466 432 CpGs), peripheral blood at age 7 years (471 347 CpGs)
and peripheral blood at age 15/17 years (469 902 CpGs), respect-
ively. The Accessible Resource for Integrated Epigenomic Studies
(ARIES) cohort is gender-balanced, with 49%males; average birth
weightwas 3.48 kg andGA 39.6weeks (Table 1). Averagematernal
age was 29.2 years; 61% of mothers had never smoked, whereas
11% continued to smoke during pregnancy.
Gestational age
EWAS
Therewas evidence for an association betweenGAand cord blood
methylation at 224 different probes annotated to 155 genes
(Table 2 and Supplementary Material, Table S1), after correcting
for cell type composition in blood using the method described
by Houseman et al. (36). GA had a negative association with
methylation at 188 probes and a positive association at 36 probes.
There was no strong evidence for any associations between GA
and peripheral blood methylation measured at age 7 or 15/17.
Replication
Of the 224 probes identified here, 129 were among the 9637 previ-
ously reported by the Nashville Birth (NB) cohort (7) [P = 1.8e−156,
Fisher’s exact test (FET)], and 5 were among the 40 reported for
Women’s Mental Health Program (WMHP) and replicated in Con-
ditions Affecting Neurocognitive Development and Learning in
Table 1. Characteristics of the ARIES sample
Mean (SD) N (%)
Birth weight 3484 (488)
Gestational age at delivery 39.6 (1.5)
<37 weeks 27 (3)
37–41 weeks 821 (90)
>41 weeks 61 (7)
Sex
Male 445 (49)
Female 469 (51)
Parity 0.7 (0.8)
Maternal age 29.2 (4.4)
Maternal smoking
Never 545 (61)
Quit 248 (28)
Smoker 101 (11)
Delivery method
Caesarean 83 (9)
Natural 795 (91)
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Early Childhood (CANDLE; P = 1.3e−11, FET) (5). In each case of
common findings, the direction of association is replicated in
addition to strong evidence for association. Finally, 72 of the
probes (Supplementary Material, Table S1) associated with GA
in cord blood overlapped with the 1555 found in an epigenome-
wide case–control study of preterm birth (19). Among ARIES,
WMHP, CANDLE and NB, there were three probes commonly as-
sociated with GA: cg21842274 (CRHBP), cg25551168 (AVP) and
cg05294455 (MYL4) (5,7). Of these, only cg05294455 (MYL4) (5,7)
was also common to the case–control study of preterm birth (19).
Longitudinal analysis
The results of longitudinal analysis of methylation from these
224 probes during childhood and adolescence are provided in
Table 2 and Supplementary Material, Table S1. Methylation at
the vast majority of the 188 probes showing a negative relation-
ship with GA continued to decrease during childhood. For ex-
ample, the change in methylation at cg25551168 (AVP) is shown
in Figure 1. From an estimated 54.2% in cord blood, methylation
decreased by 2.7% per year on average during early childhood and
then reached a plateau during adolescence with negligible
change in methylation from 7 to 17 years. This pattern of rapid
change during early childhood followed by stabilization during
adolescence is evident across the majority of CpG sites.
Of the 188 negatively associated probes, therewere 160 where
GA was associated with childhood changes (from 0 to 7 years) in
methylation (i.e. where an interaction between GA and age was
found). Almost all of the observed interactions are positive, which
suggests that those childrenwitha shorter gestationperiodhave fas-
ter methylation change during childhood, i.e. methylation differ-
ences at birth are resolving during childhood. There was no strong
evidence foraneffectofGAonmethylationchanges fromage7 to17.
Of the 36 probes which had increasedmethylation per week of
gestation, 34 continued to increase in methylation during child-
hood. The maximum increase was 6.7% per year between birth
and 7 years (EBF4). However, just 5 of the 36 had an increase in
methylation between 7 and 17 years, suggesting that methylation
levels had largely stabilized by age 7. An interaction between GA
and methylation changes from birth to age 7 was identified for
31 of the 36 positively associated probes. Each of these suggests
that children with shorter gestation have a faster rate of change
in methylation during childhood, which again suggests that
methylation differences attributed to GA are resolving during
early life. For example, the average cord blood methylation at
cg25551168 (AVP) was 54.7% and for eachweek of GA,methylation
was 0.7% lower on average, such that childrenwithGAof 40weeks
would be estimated to have a 7% lower methylation than those
with GA of 30 weeks, on average. We found that methylation
decreased by 2.7% per year but that for each extra week of GA
the change in methylation is slowed down by 0.1% per year.
Thus, children with a 40-week GA at delivery would lose 1.7%
methylation per year, compared with 2.7% per year for children
with 30-week GA, on average. Thus, at age 7, children with GA of
30 or 40weekswould have equalmethylation on average, explain-
ing a lack of an association between GA and methylation or
methylation change at or beyond age 7.
Birth weight
EWAS
We identified 23 probes in 14 genes where cord blood methylation
was associated with birth weight (7 probes did not have a RefSeq
gene annotation; Table 3). Birth weight was positively associated
with cord bloodmethylation at 10 probes andnegatively associatedT
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at 13. There was no strong evidence for an association between
birth weight and peripheral blood methylation at age 7 or 15/17.
Replication
Of the 23 associations observed between birth weight and cord
blood methylation, two had been previously shown to have a
negative association (8) in the Norwegian Mother and Child
(MoBa) cohort (37). Thesewere cg20076442 (no RefSeq gene)with-
out a local gene, and cg25953130 (ARID5B).
Longitudinal analysis
Longitudinal analysis of methylation at these probes showed that
11 of the 13 sites negatively associated with birth weight had a re-
duction inaveragemethylationduringchildhood (Table 3). Beyond
age 7, 7 of these 13 probes demonstrated a continued reduction
in average methylation levels. The most pronounced change
in methylation occurred in cg20076442 (no RefSeq gene). Cord
blood methylation was estimated to be 72.4% and this decreased
by 4.3% per year from birth to age 7 on average. This reduction in
methylation continued throughout later childhood and adoles-
cence, but at a rate of 0.11% per year (Fig. 2).
Probes with methylation levels which were positively asso-
ciatedwith birthweight tended to increase inmethylation during
childhood and adolescence. During childhood (age 0–7), an inter-
action between birth weight and agewas found for each of the 23
probes. Across all probes, lower birth weight was associated with
faster changes inmethylation during childhood, i.e. birthweight-
relatedmethylation differences resolved during childhood. There
was no strong evidence that birth weight was associated with
methylation change between ages 7 and 17.
Exploration of phenotypic differences in adolescence
With 224 identified probes in the EWAS of GA and 10 selected devel-
opmental phenotypes (height, weight, leg length, lean mass, fat
mass, bone mass, bone mineral density, IQ, forced expiratory vol-
umeand forcedvital capacity), therewereapossible 2240association
between GA-related methylation and developmental phenotypes.
Of these, 70 probe–phenotype associations were observed, yet just
two GA–phenotype associations were observed (with leg length
and IQ). However, neither of these associations overlapped so
there is no support in this data set for methylation differences in
these probes being associated with later phenotypic differences.
In the birth weight EWAS, 23 probes were identified such that
230 probe–phenotype association tests were performed. Of these,
14 probe–phenotype associations were observed while all 10 de-
velopmental phenotypes were associated with birth weight. The
14 overlapping associations are presented in Table 4. Therewas a
strong positive association between birth weight and develop-
ment and a negative relationship between methylation and de-
velopment in 12 of the 14 phenotypes (i.e. lower methylation
was associated with better development). Of the 14 associations,
eight involved methylation at cg15783941(NFIX) and five were
found in two CpG sites in the LTA gene. Longitudinal analysis
showed that estimated cord blood methylation at cg15783941
(NFIX) is 75.4% and this increases by 1.4% per year on average dur-
ing childhood with no evidence for further methylation change
beyond age 7 (Fig. 3). Given the observed association between
cord blood methylation and later phenotypes, there is support
here for differences at birth having longer term effects.
Discussion
Summary
We identified 224 CpG sites where cord blood methylation was
found to be associated with GA across the normal range of gesta-
tion. These included an appreciable overlap with previously
identified associations including three probes that have previ-
ously been reported in three separate cohorts (5,7) and one
probe which was common to all four cohorts (5,7,19). An EWAS
Figure 1. Change in methylation at cg25551168 during childhood and adolescence.
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Table 3. Probes at which cord blood methylation is associated with birth weight
Probe EWAS results Longitudinal analysis results
Associated gene Chr Coordinates t-statistic P-value FDR P-value Average cord blood
methylation (%)
Average yearly
change between
0 and 7 (%)
Average yearly
change between
7 and 17 (%)
Average difference
in childhood yearly
change, per kg
increase in BWT (%)
Probes with a negative association between birth weight and methylation in both the ARIES and MoBa cohorts (8)
cg20076442 NA 8 72 907 751 −5.89 6.01E−09 2.92E−04 72.4 −4.3 −0.11 0.38
cg25953130 ARID5B 10 63 423 556 −5.83 8.23E−09 3.31E−04 55.1 n/a n/a 0.60
Probes with a negative association between birth weight and methylation in the ARIES cohort only
cg04521626 PLD2 17 4 661 168 −6.60 8.01E−11 3.89E−05 57.2 −3.5 n/a 0.40
cg14097568 NA 1 94 565 530 −6.18 1.06E−09 1.62E−04 53.7 −1.9 −0.51 0.37
cg17133774 CHD5 1 6 121 254 −6.06 2.17E−09 2.11E−04 30.0 −2.8 n/a 0.74
cg00654448 NA 8 142 434 497 −5.93 4.83E−09 2.61E−04 16.5 −0.8 n/a 0.38
cg00442282 RARA 17 35 724 590 −5.84 7.77E−09 3.31E−04 25.3 −1.1 −0.08 0.39
cg13696490 LOC201651 3 152 970 696 −5.82 8.87E−09 3.31E−04 66.6 0.4 −0.47 0.37
cg12044213 CCHCR1;TCF19 6 31 232 957 −5.69 1.83E−08 5.54E−04 67.0 −2.0 −0.27 0.23
cg08817867 NA 17 19 597 146 −5.65 2.29E−08 6.16E−04 42.7 −1.9 n/a 0.62
cg00382138 CFI;CFI 4 110 942 748 −5.64 2.50E−08 6.39E−04 67.6 −1.1 −0.17 0.56
cg06870470 DOCK6 19 11 176 767 −5.58 3.39E−08 8.24E−04 34.3 −3.3 n/a 0.29
cg25557739 NA 14 96 814 038 −5.46 6.73E−08 1.49E−03 41.5 −1.2 −0.24 0.09
Probes with a positive association between birth weight and methylation in the ARIES cohort only
cg24324628 NHSL1 6 138 908 575 6.41 2.62E−10 6.36E−05 80.8 0.9 −0.06 −0.28
cg15783941 NFIX 19 12 993 221 6.14 1.33E−09 1.62E−04 75.4 1.4 n/a −0.35
cg14597739 LTA 6 31 647 977 6.03 2.63E−09 2.13E−04 65.3 0.2 0.11 −0.39
cg22962123 HOXA3 7 27 120 130 6.00 3.12E−09 2.17E−04 81.2 1.1 n/a −0.38
cg05851442 HOXA3 7 27 119 737 5.94 4.55E−09 2.61E−04 79.8 1.3 n/a −0.46
cg23387597 ITPRIP 10 106 083 768 5.77 1.15E−08 3.98E−04 82.9 0.4 0.05 −0.30
cg24973755 MAEA 4 1 294 972 5.70 1.75E−08 5.54E−04 76.3 0.2 −0.15 −0.42
cg16219283 LTA 6 31 647 981 5.68 1.94E−08 5.54E−04 68.0 n/a 0.13 −0.27
cg25799241 NA 8 144 877 728 5.46 6.46E−08 1.49E−03 68.2 1.9 n/a −0.32
cg06658067 NA 16 29 301 844 5.45 7.05E−08 1.49E−03 73.6 n/a −0.04 −0.17
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of birth weight discovered associations with DNAmethylation at
23 CpG sites. Of these, two probes have been previously identified
in theMoBa cohort (8). Therewas little evidence of an association
between methylation at age 7 or 17 years and either of birth
weight or GA. This is suggestive of the non-persistence of birth-
related DNA methylation differences and implies that much of
the variation in birth-related DNA methylation observed at
birth attenuates markedly in the first few years of life. Indeed,
there appears to be a phase of rapid ‘catch-up’ inmethylation dif-
ferences. This observation has important implications for the
role of epigenetic processes in developmental programming (in
blood); although it does not preclude the involvement of epigen-
etic mechanisms per se, it suggests that any downstream con-
sequences of these specific epigenetic perturbations observed
at birth may be set in train during early life rather than the
marks themselves persisting across the life course. These infer-
ences are limited to differential methylation associated with
GA and birth weight and may not extend to all changes induced
in utero, exemplified by the smoking-responsive changes in DNA
methylation recently reported which can persist for longer
periods of time (38,39).
Longitudinal analysis provided evidence that methylation le-
vels change rapidly during early development. For themajority of
probes with changing methylation levels, this change was more
pronounced during the immediate postnatal years, with many
sites tending to stabilize in methylation level beyond age 7.
Where interactions were found, lower birth weight and shorter
GAwere associatedwith an increased rate ofmethylation change
during the life course, suggesting a ‘catch-up’ mechanism in
early life. The resolution of cord blood methylation differences
Figure 2. Change in methylation at cg20076442 during childhood and adolescence.
Table 4. Results of developmental phenotypes’ association with DNA methylation and birth weight
Phenotype Probe Gene t-statistic
(methylation)
P-value
(methylation)
t-statistic
(birth weight)
P-value (birth
weight)
Lean mass 17 cg12044213 CCHCR1;TCF19 4.32 1.76E−05 14.95 <1E−16
Height 17 cg14597739 LTA −4.24 2.49E−05 18.13 <1E−16
Lean mass 17 cg14597739 LTA −4.75 2.42E−06 14.95 <1E−16
FVC 15 cg14597739 LTA −4.06 5.37E−05 11.82 <1E−16
FVC 15 cg15783941 NFIX −6.71 3.87E−11 11.82 <1E−16
Weight 17 cg15783941 NFIX −4.65 3.91E−06 15.59 <1E−16
Bone mass 17 cg15783941 NFIX −6.73 3.21E−11 16.31 <1E−16
Fat mass 17 cg15783941 NFIX 4.14 3.91E−05 5.26 1.42E−07
BMD 17 cg15783941 NFIX −5.55 3.97E−08 8.74 <1E−16
Height 17 cg15783941 NFIX −9.05 1.07E−18 18.13 <1E−16
FEV1 15 cg15783941 NFIX −5.60 2.96E−08 12.15 <1E−16
Lean mass 17 cg15783941 NFIX −10.96 4.56E−26 14.95 <1E−16
FVC 15 cg16219283 LTA −3.85 1.28E−04 11.82 <1E−16
Lean mass 17 cg16219283 LTA −3.72 2.10E−04 14.95 <1E−16
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during childhood has been recently reported (40) at differentially
methylated probes (DMPs) related to pre-pregnancy maternal
BMI. However, this is in contrast to changes in methylation
at smoking-responsive probes, where differences in cord blood
methylation associated with maternal smoking have been
shown to persist through childhood and adolescence (39). Two
previous studies have sought to investigatemethylation changes
in early life, from birth to 6 months (34) and from birth to 18
months in twins (33). Using two time points, they performed
paired t-tests and established that 30% of 330 168 probes under
investigation had methylation which changed in the first
18 months, with an average increase of 3.1% per year (33). In con-
trast, our longitudinal analysis was not epigenome-wide and
investigated change in only those DMPs identified in cord blood
in relation to birth weight or GA. The questions addressed are
therefore different; one establishing the difference inmethylation
across themethylome between two ages, and the other establish-
ing the extent of changeover time in loci shown tobedifferentially
methylated with regard to a specific trait. In contrast to the 1% of
the probes previously shown to differ between birth and 12
months of age (5), our study suggests that the vast majority of
GA- (87%, 190/224) and birth weight (87% 20/23)-associated DMPs
undergo a period of rapid change. The lower estimate of change
found by Martino et al. (34) may relate to the cell type studied,
CD4+ cells rather thanwhole blood cells and the shorter time per-
iod, 1 year compared with the 7 years in the current study. More-
over, our findings do not necessarily contradict the previous
results because the CpG sites perturbed by GA and birth weight
are likely to be specifically targeted by the ‘catch-up’ mechanism
discussed above that resolves GA and birth weight-related
changes in early life.
Birth weight-related cord blood methylation in the NFIX gene
was shown to be associated with developmental phenotypes,
which were also associated with birth weight, including bone
mineral density at 17 years of age. NFIX regulates the develop-
ment of the brain and of bone and skeletal muscle. NFIX has
been identified previously as having birth weight-associated le-
vels of DNA methylation (6). Birth weight-associated sites near
the transcription start of LTAwere also associated with develop-
mental phenotypes including lean mass. LTA is a tumour necro-
sis factor family member produced by lymphocytes and is
integrally involved in the development of secondary lymphoid
organs both before and shortly after birth (41) as well as in a
wide variety of immune responses. Previous work has also iden-
tified likely associations between cord blood methylation in the
region of the endothelial nitric oxide synthase gene (eNOS) and
bone mineral density at 9 years (42). We observed an association
with GA in a neighbouring gene promoter (KCNH2) less than
40 Kb away.
Comparison with previous EWAS
Our analyses replicate the findings of several previous studies
(5,7,8). Among these are two GA-related probes in the AVP gene,
which has been linked together with the OXT gene to the timing
of delivery (43). Suggestively, nearby associated probes were
identified in the promoter of OXT in our cohort ARIES and in
WMHP and CANDLE (5) though not at precisely the same probes.
Another is a probe adjacent to the transcription start site of the
CRHBP gene. CRHBP encodes a protein produced by the placenta,
but that drops dramatically prior to parturition in order to
promote corticotropin-releasing hormone activity (7). Whereas
previous studies identified an association near the ESR1 gene,
also known to play a role in parturition, no such associations
were found in the ARIES cohort. A third associated probe
(cg05294455) is located about 100 bp upstream of the MYL4 gene
that encodes a motor protein involved in muscle contractions.
Salomonis et al. (44) show that MYL4 is one of the most down-
regulated transcripts in the mouse myometrium during late
gestation and note that theMYL4 plays a primary role in uterine
contraction at term. In human cord blood, we show that MYL4
methylation is positively associated with GA possibly implying
Figure 3. Change in methylation at those sites found to be associated with birth weight and later developmental phenotypes.
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a negative associationwithMYL4 gene expression in contrast to a
positive association in the myometrium. This is consistent with
the observation of Cruickshank et al. (19) of large methylation
decrease at the same probe in neonatal blood spots of preterm in-
fants compared with term infants. The relationship between
blood DNA methylation of these parturition-related genes and
timing of delivery remains to be elucidated.
Of the three regional associations identified by Lee et al. (6), we
replicated one near theMSRB3 gene encoding a product that cat-
alyzes the reduction of methionine sulphoxide to methionine. It
has been hypothesized that increased levels of methionine
sulphoxide in body tissues contribute to aging (45,46). The nega-
tive association between DNA methylation and GA that we
observe suggests that MSRB3 may be more highly expressed in
cord blood at later GAs.
Unlike Paret et al. (7), we did not observe associations at probes
near key epigenetic genes DNMT1, DNMT3A, DNMT3B and TET1.
However, we did observe associations at the same sites near
the CHD4 and CHD5 genes that encodemembers of a nucleosome
remodelling and deacetylase complex. Paret et al. (7) observe
positive associations at probes near MMP9, which is involved in
the breakdown of the extracellular matrix in the process of cer-
vical ripening (47). We similarly observe positive associations at
probes near MMP15, another matrix metalloproteinase involved
in extracellular matrix breakdown.
Two of the 23 birth weight-related probes have previously
been identified in the MoBa cohort (8), including the same
probe in ARID5B. This gene has been shown to be associated
with postnatal adiposity in mice (14). As noted for the MoBa co-
hort (8), several birth weight-related sites (6) are linked to genes
that play important roles in development, including RAR, NFIX,
LTA andHOXA3. For example, knockout of RAR inmice induces le-
thality shortly after birth and results in testis degeneration (48),
NFIX provides foetal-specific transcription regulation in develop-
ing skeletal muscle (49), LTA is critically involved in the develop-
ment of secondary lymphoid organs both before and shortly after
birth (50), and HOXA3 is involved in patterning the cranial neural
crest (51). Therewas no overlap between our birth weight-related
probes and three probes found in a study of extremely birth
weight discordant adult twins (17).
Strengths
Amajor strength of our analysis is the ARIES data set, which con-
tains serially measured DNAmethylation on 1018 children along
with a plethora of phenotypic information. This has enabled lon-
gitudinal analysis of DNA methylation over three measurement
occasions. Using these data, we have provided an in-depth
study of methylation changes during childhood and adolescence
at methylation loci associated with birth weight and GA.
Limitations
Although we corrected for cellular heterogeneity using the
Houseman (36) algorithm, there is a different ratio of white
blood cell types in cord blood compared with peripheral blood
drawn in childhood. This raises the possibility that differences
observed can be explained by longitudinal (possibly develop-
mental) changes in white blood cell profiles. However, we used
independent surrogate variable analysis (ISVA) estimated com-
ponents to attempt to correct for changing blood composition.
Due to the unique nature of our data set and the lack of available
serial data in other cohort studies (at the current time), we have
not been able to replicate our longitudinal analysis findings in an
independent cohort, although our findings do show concordance
with other cross-sectional studies. Modelling methylation over
time at single sites rather than over regions has inherent limita-
tions. Furthermore, with only three repeatedmeasures ofmethy-
lation available, our longitudinal modelling strategy was limited.
For example, with several repeated measures available, smooth-
ing methods (52) may have been employed to accurately capture
the pattern of methylation change. With respect to interpret-
ation, more detailed modelling of correlated groups of probes or
differentially methylated regions of the genome would help to
enhance the functional relevance of our observations. Another
limitation is tissue specificity. Although convenient, use of
blood is not likely the most relevant tissue for investigating the
effects of birth characteristics on developmental phenotypes. It
is possible thatDNAmethylation perturbations in tissues that ac-
tually play a role in the phenotypes (e.g. brain tissues and IQ)
might actually persist throughout childhood. The limited associ-
ation observed between DNA methylation at birth and later
phenotype may also be related to the stringent cut-offs imposed
in our study and consideration of a larger pool of DMPs may
uncover more evidence of phenotypic consequences of birth
weight- and GA-associated differential methylation.
Conclusion
Using serially collected DNA methylation, we have provided
strong evidence for the non-persistence of epigenetic marks
that are associated with birth characteristics throughout child-
hood and adolescence. In the vast majority of probes identified
in our study,methylation levels change rapidly in the early stages
of development and then stabilize into adolescence. While birth
weight appears to have an influence on methylation changes,
there is less evidence that GA plays a role in the evolution of
long-term DNA methylation patterns. There is evidence that
birth weight-related methylation differences may be linked to
later developmental phenotypes. Replication in other tissue
types and the application of causal analysis methods are needed
to further address this hypothesis, namely that the effect of birth
weight on later developmental phenotypes is influenced in part
by DNA methylation differences at birth.
Materials and Methods
Study population
This study used DNA methylation data generated under the
auspices of the Avon Longitudinal Study of Parents and Children
(ALSPAC) (53). ALSPAC recruited 14 541 pregnant women with
expected delivery dates between April 1991 and December 1992.
Of these initial pregnancies, there were 14 062 live births and
13 988 children whowere alive at 1 year of age. The study website
contains details of all the data that are available through a
fully searchable data dictionary (http://www.bris.ac.uk/alspac/
researchers/data-access/data-dictionary).
As part of the ARIES project (http://www.ariesepigenomics.
org.uk), a sub-sample of 1018 ALSPAC child–mother pairs had
DNA methylation obtained using the Infinium HumanMethyla-
tion450 BeadChip (Illumina, Inc.) (35). In this study, we use DNA
methylation data generated from cord blood and peripheral
blood samples at age 7 and again at age 15 or 17 years, leading
to three measurements of DNA methylation per child. However,
DNA methylation data were also obtained from the mothers of
these children, from blood samples taken during pregnancy
and at a follow-up clinic 18 years later.
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Laboratory methods, QC and preprocessing
All DNA methylation wet laboratory and preprocessing analyses
were performed at the University of Bristol as part of the ARIES
project. Following extraction, DNA was bisulphite-converted
using the Zymo EZ DNA Methylation™ kit (Zymo, Irvine, CA,
USA). Infinium HumanMethylation450 BeadChips were used to
measure genome-wide DNA methylation levels at over 485 000
CpG sites. The arrays were scanned using an Illumina iScan,
with initial quality review using GenomeStudio. The assay de-
tects methylation of cytosine at CpG islands using two site-spe-
cific probes—one to detect the methylated (M) locus and one to
detect the unmethylated (U) locus. Single-base extension of the
probes incorporates a labelled chain-terminating ddNTP, which
is then stained with a fluorescence reagent. The ratio of fluores-
cent signals from the methylated site versus the unmethylated
site determines the level of methylation at the locus. The level
of methylation is expressed as a ‘beta’ value (β-value), ranging
from 0 (no cytosine methylation) to 1 (complete cytosine methy-
lation). β-values are reported as percentages.
During the data generation process, a wide range of batch
variables were recorded in a purpose-built laboratory informa-
tion management system (LIMS). The LIMS also reported QCme-
trics from the standard control probes on the 450 K BeadChip.
Samples failing QC (average probe detection P-value ≥0.01) were
repeated. Samples from all time points in ARIES were rando-
mized across arrays to minimize the potential for batch effects.
As an additional QC step, genotype probes on the 450 K BeadChip
were compared between samples from the same individual and
against SNP-chip data to identify and remove any sample mis-
matches. In addition to these QC steps, probes that contained
<95% of signals detectable above background signal (detection
P-value <0.01) (N = 7938) were excluded from analysis. After ex-
cluding these probes, as well as control probes and probes on
sex chromosomes, a total of 466 432 CpGs were included in the
main analysis for cord blood methylation. At age 7, 471 347
CpGs were included and at age 17, 469 902 CpGs were included
in the main analysis, following the same exclusion criteria. Raw
β-values were preprocessed using R (version 3.0.1) with back-
ground correction and subset quantile normalization performed
using the pipeline described by Touleimat and Tost (54). β-values
were corrected for cell type heterogeneity in blood using the
method described by Houseman et al. (36).
Statistical analysis
EWAS
Using CpGassoc (55), separate EWASs of GA and birthweightwith
cord blood methylation, peripheral blood methylation at age 7
and peripheral bloodmethylation at age 15/17 years were carried
out. As well as being mutually adjusted for GA and birth weight,
each EWAS was adjusted for parity, maternal age, maternal
smoking, child sex and delivery method (caesarean yes/no) as
potential confounders. DNA methylation M-values (i.e. logit-
transformed β-values) were used in each EWAS (56). We report
those CpG sites where an association was found at the P < 1.03 ×
10−7 level (to account for multiple testing across CpG sites). A de-
scription of each CpG site, as defined by the Illumina BeadChip
probe name and RefSeq annotation (where known), is presented.
Replication
Two previous studies have used Illumina BeadChip arrays to
identify associations with GA, the first using the 27 K BeadChip
in the WMHP cohort and the CANDLE cohort (5), and the second
using the 450 K BeadChip in the NB cohort (7). The MoBa cohort
(37) has investigated relationship between birth weight and
DNA methylation using the 450 K BeadChip (8). We compared
identified probes with those found in these EWAS [of GA (5,7)
and birth weight (8)], highlighting any replicated CpG sites. We
also compared the results of our GA EWAS with findings from a
case–control study of preterm birth (19), which used the 450 K
BeadChip.
Longitudinal analysis
Longitudinal DNA methylation data from birth to 17 years were
analysed for those CpG sites found to be associated with the
birth weight or GA. Methylation β-values from all three time
points were normalized together using the method described
by Touleimat and Tost (54) and ISVA (57) was used to generate
the top 20 components of variation. These components account
for confounding due to position effects and also any changing
cell type proportions. The methylation β-values were modelled
over time in the children using multilevel models (58,59) to ac-
count for within- and between-child variation in methylation.
Multilevel models also allow investigation of both methylation
change during childhood and the effect of birth weight/GA on
this methylation change. Irregular measurements of methyla-
tion over time (i.e. some children measured at 15 and some at
17) are handled naturally by multilevel models, introducing no
bias from this design. A linear spline term was added to allow
for different linear changes from 0 to 7 and from 7 to 17. For
example, the model for GA-related methylation changes is
methij ¼ β0 þ u0i þ β1GAþ β2ageij þ β3ðageij  7Þþ
þ β4GA × ageij þ β5GA × ðageij  7Þþ þ εij
εij ∼ Nð0; σ2εÞ
u0i ∼ Nð0; σ2uÞ
where i indexes the children inARIES, j ¼ 1; 2; 3 indexes themeas-
urement occasion, aþ¼ a if a> 0 or 0 otherwise and u0i is a ran-
dom intercept, which allows children to have different cord
blood methylation. β1 gives the average change in methylation
per week increase in GA at delivery; β2 gives the average change
in methylation from birth to adolescence; β3 is the change to
this trend (i.e. β2) from 7 to 17; β4 is the difference in methylation
change between 0 and 7 per week increase in GA at delivery; β5 is
the difference in methylation change between 7 and 17 per week
increase in GA. A random intercept-only model is reported, since
random slope models could not be fitted to these data due to the
small number of repeated measures. The models were further
adjusted for the first 20 ISVA components (which account for
variance due to changing cell type proportions and batch effects),
maternal age, maternal alcohol consumption, maternal educa-
tion, maternal smoking, parity and delivery method as potential
confounders.
Phenotypic differences in adolescence
To investigate whether observed birth characteristic-related
differences in methylation were associated with longer term
phenotypic differences, we identified a set of 10 developmental
phenotypes measured during childhood and adolescence.
These were height (cm) and weight (kg; measured at 17 years);
leg length (cm; at 11 years); lean mass (g), fat mass (g), bone
mass (g) and bone mineral density (g/cm2; 17 years); IQ (at 8
years); lung capacity [forced expiratory volume (l) in 1 second
and forced vital capacity (l) at 15 years]. These outcomes were
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chosen to represent development in size (height, weight, leg
length, lean/bone/fat mass and bone mineral density), mental
function (IQ) and physical function (lung capacity) and based
on published evidence that each has been associated with birth
weight and/or GA (60–68). Using simple linear regression, these
10 phenotypes were tested for association with birth weight/GA
as well as cord bloodmethylation from those CpG sites identified
through EWAS. To account formultiple testing, evidence for asso-
ciation was set at the P < 0.05/(10 [phenotypes] × number of CpG
sites).
Supplementary Material
Supplementary Material is available at HMG online.
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